AnalystsJoel Beatty
Joel Beatty's Stock Forecasts

Analyst Ranking
Top 23%
#796 out of 3582 analysts
Average Return
+6.46%
Win Rate
41%19 out of 46
Risk vs Reward
Poor
Good

Joel Beatty's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
CymaBay Therapeutics IncCBAY
+258.57%$1.40$5.02
2020-03-19 -
2021-03-19
Strong Buy
Esperion Therapeutics IncESPR
+197.78%$26.17$77.93
2017-02-27 -
2018-01-22
Strong Buy
Arena Pharmaceuticals IncARNA
+173.80%$15.23$41.70
2017-06-26 -
2018-06-27
Strong Buy
Ngm Biopharmaceuticals IncNGM
+120.11%$13.08$28.79
2020-03-26 -
2021-03-26
Strong Buy
Arena Pharmaceuticals IncARNA
+74.76%$25.36$44.32
2017-07-11 -
2018-07-12
Strong Buy

Joel Beatty's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Vir Biotechnology IncVIR
1Sell$36.00+9.49%Downgrades
a month ago
Cardiff Oncology IncCRDF
1Buy$19.00+424.86%Initiates Coverage On
2 months ago
Geron CorpGERN
1Buy$4.00+260.36%Initiates Coverage On
3 months ago
BeyondSpring IncBYSI
1Buy$50.00+1,419.76%Initiates Coverage On
5 months ago
Arcturus Therapeutics Holdings IncARCT
1SellN/AN/ADowngrades
5 months ago
Blueprint Medicines CorpBPMC
1Buy$123.00+70.17%Maintains
7 months ago
Argenx SeARGX
1Buy$333.00+25.66%Maintains
8 months ago
Pliant Therapeutics IncPLRX
2Strong Buy$52.00+356.54%Initiates Coverage On
10 months ago
Alnylam Pharmaceuticals IncALNY
2Hold$175.00+28.18%Downgrades
a year ago
Vanda Pharmaceuticals IncVNDA
4Hold$14.00N/ADowngrades
a year ago
Sarepta Therapeutics IncSRPT
2Hold$108.00N/ADowngrades
a year ago
Ptc Therapeutics IncPTCT
5Strong Buy$85.00N/AUpgrades
a year ago
Eidos Therapeutics IncEIDX
2Hold$73.26N/ADowngrades
a year ago
Eloxx Pharmaceuticals IncELOX
1Hold$4.00N/ADowngrades
2 years ago
Ayala Pharmaceuticals IncAYLA
1Strong Buy$25.00N/AInitiates Coverage On
2 years ago
Tempest Therapeutics IncTPST
2Strong Buy$6.00N/AReinstates
2 years ago
Ionis Pharmaceuticals IncIONS
2Strong Buy$71.00N/AMaintains
2 years ago
PhaseBio Pharmaceuticals IncPHAS
1Strong Buy$11.00N/AMaintains
2 years ago
DBV Technologies SADBVT
2Strong Buy$10.00N/AMaintains
2 years ago
Amarin Corp PlcAMRN
3Strong Buy$6.00N/AMaintains
2 years ago
Ngm Biopharmaceuticals IncNGM
1Strong Buy$28.00N/AMaintains
2 years ago
X4 Pharmaceuticals IncXFOR
1Strong Buy$15.00N/AMaintains
2 years ago
CymaBay Therapeutics IncCBAY
1Strong Buy$1.60N/AMaintains
2 years ago
Esperion Therapeutics IncESPR
5Strong BuyN/AN/AUpgrades
2 years ago
Intercept Pharmaceuticals IncICPT
5Strong BuyN/AN/AUpgrades
2 years ago
Syndax Pharmaceuticals IncSNDX
1Strong Buy$12.00N/AMaintains
3 years ago
Medicines CoMDCO
3Strong Buy$50.00N/AMaintains
3 years ago
aTYR PHARMA INCLIFE
1Hold$0.75N/AUpgrades
3 years ago
Astria Therapeutics IncATXS
3Strong Buy$1.50N/AMaintains
3 years ago
Arena Pharmaceuticals IncARNA
3Strong Buy$55.00N/AMaintains
4 years ago
Novavax IncNVAX
3Hold$2.75N/AMaintains
4 years ago
Kura Oncology IncKURA
1Strong Buy$19.00N/AMaintains
4 years ago
Dimension Therapeutics IncDMTX
3HoldN/AN/AUpgrades
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.